| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |